ImmuPharma plc (LON:IMM – Get Free Report)’s share price dropped 3.9% on Tuesday . The company traded as low as GBX 3.21 ($0.04) and last traded at GBX 3.60 ($0.04). Approximately 5,849,024 shares were traded during mid-day trading, a decline of 79% from the average daily volume of 27,497,447 shares. The stock had previously closed at GBX 3.75 ($0.05).
ImmuPharma Stock Performance
The firm has a market capitalization of £10.64 million, a PE ratio of -255.50 and a beta of 1.53. The firm’s 50 day moving average price is GBX 1.54 and its 200-day moving average price is GBX 1.68.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Featured Articles
- Five stocks we like better than ImmuPharma
- What Makes a Stock a Good Dividend Stock?
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- P/E Ratio Calculation: How to Assess Stocks
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
- Earnings Per Share Calculator: How to Calculate EPS
- D-Wave’s Stock Springs Back in the Quantum Computing Race
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
